Our patented, proprietary MAP™ extraction platform safely extracts active natural compounds from a wide range of biological materials at rapid speed, providing superior customer outcomes in terms of ingredient purity, yield, and cost.
Headquartered in Edmonton, Alberta, and fast becoming a global company, we work closely with our clients every step of the way to help them develop the highest quality naturally derived products. Radient is fully GMP compliant, Health Canada approved, and NNHPD certified.
Radient is founded in Vancouver, B.C. by Dr. Steven Splinter (Radient’s current CTO) and Vizon SciTec Inc. (“Vizon”), formerly BC Research Inc., in order to pursue commercial applications of the patented MAP™ natural product extraction technology.
Radient enters into agreement with Vizon to acquire the rights to the MAP™ license Vizon previously had with Environment Canada, and begins operations in laboratory and pilot plant facilities located within an Environment Canada facility in Burlington, Ontario.
After raising venture capital financing, Radient signs its first supply agreement with a US-based biopharmaceutical company to supply purified pharmaceutical raw ingredients extracted and isolated from a natural plant source using MAP™ technology.
Radient acquires its own leased laboratory and pilot plant facilities in North York, Ontario and Whitby, Ontario. During this period Radient continues to successfully commercialize its MAP™ technology platform and demonstrate its capabilities.
As Radient continues to grow its revenues and pipeline of customers, demand begins to exceed the capacity of its Whitby pilot plant.
Radient headquarters is relocated to Edmonton, where construction begins on its brand new, 20,000 sq. ft. Manufacturing Facility capable of processing 5 metric tons of biomass per day.
Radient goes public on the TSX Venture Exchange, trading under the symbol “RTI”.
Radient signs MOU with Aurora Cannabis Inc. to evaluate an exclusive partnership for the joint development and commercialization of superior and standardized cannabinoid extracts.
The Company announces it will build additional cannabis and hemp manufacturing facilities in Edmonton, as well as a brand new cannabis and hemp manufacturing facility in Germany, expected to be complete in 2020.
Radient’s global Executive Team is comprised of leaders in the fields of Science, Technology, Biotech, Engineering, Corporate Finance, and Global Corporate Strategy.
The members of Radient’s highly experienced Board of Directors hails from a range of industries and have held leadership positions at world-renowned companies such as L’Oreal, Gencor, Goldman Sachs, Amnor Group, and Aurora Cannabis Inc.